Skip to main content
Top
Published in: Supportive Care in Cancer 8/2007

01-08-2007 | Original Article

How to summarise and report written qualitative data from patients: a method for use in cancer support care

Authors: Marie J. Polley, Helen E. Seers, Helen J. Cooke, Caroline Hoffman, Charlotte Paterson

Published in: Supportive Care in Cancer | Issue 8/2007

Login to get access

Abstract

Goals of work

The goal of this study is the determination of key themes to aid the analysis of qualitative data collected at three cancer support centres in England, using the Measure Yourself Concerns and Wellbeing (MYCaW) questionnaire.

Patients and methods

People with cancer who use complementary therapies experience and value a wide range of treatment effects, yet tools are urgently required to quantitatively measure these outcomes. MYCaW is an individualised questionnaire used in cancer support centres providing complementary therapies, scoring ‘concerns or problems’ and ‘well-being’ and collecting qualitative data about other major events in a patient’s life and what has been most important to the patient. Content analysis on 782 MYCaW questionnaires from people at these cancer support centres was carried out. The ‘concerns,’ ‘other things going on in their life’ and ‘important aspects of centre’ were thematically categorised and externally validated by a focus group, and the inter-rater reliability was calculated.

Main results

Clinical information from a cancer patient’s perspective was collected that is not measured on standard quality-of-life questionnaires; furthermore, some themes acknowledge the multi-faceted aspects of complementary and alternative medicine provision, rather than information only relating to the therapeutic intervention. Categories for qualitative MYCaW analysis have been established providing a tool for future research and/or service delivery improvement within cancer support centres such as these.

Conclusions

The established themes provide a framework to aid analysis of qualitative aspects of complementary therapy care for people with cancer, improving our understanding of how the patient’s cancer experience can be aided by complementary therapies in specialised cancer centres.
Footnotes
1
The inclusion criteria category information and instructions for new users can be accessed on the MYMOP website: http://​www.​bristol.​ac.​uk/​hsrc/​research/​other/​mymop.
 
Literature
1.
go back to reference Armstrong D, Gosling A, Weinman J, Marteau T (1997) The place of inter-rater reliability in qualitative research. Sociology 31:597–606CrossRef Armstrong D, Gosling A, Weinman J, Marteau T (1997) The place of inter-rater reliability in qualitative research. Sociology 31:597–606CrossRef
2.
go back to reference Barry C, Barry CA, Britten N, Barber N, Bradley C, Stevenson F (1999) Using reflexivity to optimise teamwork in qualitative research. Qual Health Res 9:26–44PubMedCrossRef Barry C, Barry CA, Britten N, Barber N, Bradley C, Stevenson F (1999) Using reflexivity to optimise teamwork in qualitative research. Qual Health Res 9:26–44PubMedCrossRef
3.
go back to reference Bowling A (1995) Measuring disease. A review of disease-specific quality of life measurement scales. Open Univ. Press, Buckingham, p 21 Bowling A (1995) Measuring disease. A review of disease-specific quality of life measurement scales. Open Univ. Press, Buckingham, p 21
4.
go back to reference Ernst E, Cassileth BR (1998) The prevalence of complementary and alternative cancer: a systematic review. Cancer 53:2736–2740 Ernst E, Cassileth BR (1998) The prevalence of complementary and alternative cancer: a systematic review. Cancer 53:2736–2740
5.
go back to reference Long AF, Mercer G, Hughes K (2000) Developing a tool to measure holistic practice: a missing dimension in outcomes measurement within complementary therapies. Complement Ther Med 8:26–31PubMed Long AF, Mercer G, Hughes K (2000) Developing a tool to measure holistic practice: a missing dimension in outcomes measurement within complementary therapies. Complement Ther Med 8:26–31PubMed
6.
go back to reference Meenan R (2001) Developing appropriate measures of the benefits of complementary and alternative medicine. J Health Serv Res Policy 6:38–43PubMedCrossRef Meenan R (2001) Developing appropriate measures of the benefits of complementary and alternative medicine. J Health Serv Res Policy 6:38–43PubMedCrossRef
7.
go back to reference Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott GA, Panteli V et al (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:665–663CrossRef Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott GA, Panteli V et al (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:665–663CrossRef
8.
go back to reference Moris J (1991) Measurement of quality of life: how to choose an appropriate test. Cancer Topics 8:75–76 Moris J (1991) Measurement of quality of life: how to choose an appropriate test. Cancer Topics 8:75–76
9.
go back to reference Paterson C (2004) Seeking the patient’s perspective: a qualitative assessment of EurQol, COOP-WONCA charts and MYMOP. Qual Life Res 13:871–881PubMedCrossRef Paterson C (2004) Seeking the patient’s perspective: a qualitative assessment of EurQol, COOP-WONCA charts and MYMOP. Qual Life Res 13:871–881PubMedCrossRef
10.
11.
go back to reference Paterson C, Britten N (2000) In pursuit of patient-centred out-comes: a qualitative evaluation of MYMOP, Measure Yourself Medical Outcome Profile. J Health Serv Res Policy 5:27–36PubMed Paterson C, Britten N (2000) In pursuit of patient-centred out-comes: a qualitative evaluation of MYMOP, Measure Yourself Medical Outcome Profile. J Health Serv Res Policy 5:27–36PubMed
12.
go back to reference Paterson C, Thomas K, Manasse A, Cooke H, Peace G (2006) Measure Yourself Concerns and Wellbeing (MYCaW): an individualised questionnaire for evaluating outcome in cancer support care that includes complementary therapies. Complement Ther Med 15:38–45PubMedCrossRef Paterson C, Thomas K, Manasse A, Cooke H, Peace G (2006) Measure Yourself Concerns and Wellbeing (MYCaW): an individualised questionnaire for evaluating outcome in cancer support care that includes complementary therapies. Complement Ther Med 15:38–45PubMedCrossRef
13.
go back to reference Peace G, Manasse A (2002) The Cavendish Centre for integrated cancer care: assessment of patients’ needs and responses. Complement Ther Med 10:33–41PubMedCrossRef Peace G, Manasse A (2002) The Cavendish Centre for integrated cancer care: assessment of patients’ needs and responses. Complement Ther Med 10:33–41PubMedCrossRef
14.
go back to reference Risberg T, Kaasa S, Wist E, Melsom H (1997) Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur J Cancer 33:575–580PubMedCrossRef Risberg T, Kaasa S, Wist E, Melsom H (1997) Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur J Cancer 33:575–580PubMedCrossRef
15.
go back to reference Rodeheaver PF, Taylor AG, Lyon DE (2003) Incorporating patients’ perspective in complementary and alternative medicine clinical trial design. J Altern Complement Med 9:959–967PubMedCrossRef Rodeheaver PF, Taylor AG, Lyon DE (2003) Incorporating patients’ perspective in complementary and alternative medicine clinical trial design. J Altern Complement Med 9:959–967PubMedCrossRef
16.
go back to reference Sparber A, Wootton JC (2001) Surveys of complementary and alternative medicine: part II use of alternative and complementary cancer therapies. J Altern Complement Med 7:281–287PubMedCrossRef Sparber A, Wootton JC (2001) Surveys of complementary and alternative medicine: part II use of alternative and complementary cancer therapies. J Altern Complement Med 7:281–287PubMedCrossRef
17.
go back to reference Vaghela C, Robinson N, Gore J, Peace B, Lorenc A (2007) A pilot study: Complementary Therapies in Clinical Practice (in press) Vaghela C, Robinson N, Gore J, Peace B, Lorenc A (2007) A pilot study: Complementary Therapies in Clinical Practice (in press)
18.
go back to reference Verhoef M, Balneaves LG, Boon H, Vroegindewey A (2005) Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 4:274–286PubMedCrossRef Verhoef M, Balneaves LG, Boon H, Vroegindewey A (2005) Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 4:274–286PubMedCrossRef
19.
go back to reference Verhoef MJ, Mulkins A, Boon H (2005) Integrative health care: how can we determine whether patients benefit? J Altern Complement Med 11:S57–S65PubMedCrossRef Verhoef MJ, Mulkins A, Boon H (2005) Integrative health care: how can we determine whether patients benefit? J Altern Complement Med 11:S57–S65PubMedCrossRef
20.
go back to reference Waitzkin H (1991) The politics of medical encounters. Yale Univ. Press, New Haven Waitzkin H (1991) The politics of medical encounters. Yale Univ. Press, New Haven
21.
go back to reference White MA, Verhoef MJ (2005) Toward a patient-centred approach: incorporating principles of participatory action research into clinical studies. Integr Cancer Ther 4:21–24PubMedCrossRef White MA, Verhoef MJ (2005) Toward a patient-centred approach: incorporating principles of participatory action research into clinical studies. Integr Cancer Ther 4:21–24PubMedCrossRef
22.
go back to reference Zebrack S (2000) Cancer survivors and quality of life: a critical review of the literature. Oncol Nurs Forum 27:1395–1401PubMed Zebrack S (2000) Cancer survivors and quality of life: a critical review of the literature. Oncol Nurs Forum 27:1395–1401PubMed
Metadata
Title
How to summarise and report written qualitative data from patients: a method for use in cancer support care
Authors
Marie J. Polley
Helen E. Seers
Helen J. Cooke
Caroline Hoffman
Charlotte Paterson
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 8/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0283-2

Other articles of this Issue 8/2007

Supportive Care in Cancer 8/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine